Compare Johnson & Johnson (JNJ) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Kraft Heinz Co — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while Kraft Heinz Co trades at $22.27 (market cap $26.66B). The key difference: Johnson & Johnson is far larger — about 23.2× Kraft Heinz Co's market cap, and Kraft Heinz Co pays the higher dividend (7.12%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Kraft Heinz Co for 129 Days on average.
| JNJ | KHC | |
|---|---|---|
Market Cap | $618.09B | $26.66B |
Volume | 6,050,983 | 31,300,109 |
Sector | Health | Consumer Staples |
52-Week High | $278.43 | $27.62 |
52-Week Low | $186.00 | $21.21 |
Typical Hold Time | 129 Days | 129 Days |
Enterprise Value | $646.37B | $42.98B |
Dividend Yield | 2.09% | 7.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 28.45% net profit margin and consistent revenue growth to $94.19B in 2025. Analyst consensus remains positive with a $286.53 price target, though technical indicators show resistance at $258 and support at $253. Recent news highlights pipeline strength including Icotyde's $4.5B peak sales potential (Bank of America, 2026-09-29).
JNJ presents a compelling long-term investment with diversified healthcare exposure and dividend stability, though near-term technical weakness and patent cliff concerns warrant caution. The 52.5% buy rating from analysts reflects confidence in innovation pipeline, while debt-to-asset ratio increase to 24.06% merits monitoring. Upside potential exists if Q3 earnings beat expectations on October 13.
Kraft Heinz (KHC) trades at $22.48, up 2.27% on the day, with a bearish technical signal and mixed fundamentals. The stock shows a low P/E of 13.04 and P/B of 0.74, but negative net income and ROE reflect profitability challenges. Recent earnings have beaten estimates, and the company maintains a $0.40 dividend. Cash flow improved in 2025, though revenue declined to $24.94 billion. News highlights turnaround efforts, including new product launches and a halted breakup plan.
The outlook is cautious; while valuation appears cheap and dividends attract income investors, persistent negative margins and high debt pose risks. Analyst consensus is mixed with a $24.50 price target, but bearish sentiment and competitive pressures suggest limited near-term upside. Investors should weigh the dividend yield against execution risks in the consumer goods sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
